Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass

Publisher： Bentham Science Publishers

E-ISSN： 2212-3962|7|3|165-169

ISSN： 1574-8901

Source： Recent Patents on Cardiovascular Drug Discovery, Vol.7, Iss.3, 2012-12, pp. : 165-169

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic :Management of Perioperative Systemic Inflammation During Cardiopulmonary Bypass: We Need a Multimodal Approach)

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 163-164

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Comprehension and the Management of Perioperative Systemic Host Response During Cardiopulmonary Bypass

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 180-185

Bentham Science Publishers

Access to resources Recommend Favorite

What is a normal lactate level during cardiopulmonary bypass?

By Svenmarker Staffan   Häggmark Sören   Östman Margareta  

Scandinavian Cardiovascular Journal, Vol. 40, Iss. 5, 2006-10 ,pp. : 305-311

Informa Healthcare

Access to resources Recommend Favorite

Review of the Fibrinolytic System: Comparison of Different Antifibrinolytics used During Cardiopulmonary Bypass

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 3, 2012-12 ,pp. : 175-179

Bentham Science Publishers

Access to resources Recommend Favorite

Bivalirudin: Alternative Anticoagulation During Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 20-24

Bentham Science Publishers

Access to resources Recommend Favorite